Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes (Q42833865)

8 November 2017

Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes (English)

1 reference

8 November 2017

0 references

0 references

0 references

S J Creely

1

1 reference

8 November 2017

P G McTernan

2

1 reference

8 November 2017

C M Kusminski

3

1 reference

8 November 2017

ff M Fisher

4

1 reference

8 November 2017

N F Da Silva

5

1 reference

8 November 2017

M Khanolkar

6

1 reference

8 November 2017

M Evans

7

1 reference

8 November 2017

A L Harte

8

1 reference

8 November 2017

S Kumar

9

1 reference

8 November 2017

language of work or name

1 reference

7 November 2006

1 reference

American Journal of Physiology - Endocrinology and Metabolism

8 November 2017

1 reference

8 November 2017

292

1 reference

8 November 2017

E740-7

1 reference

8 November 2017

3

1 reference

IKK-beta links inflammation to obesity-induced insulin resistance

8 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

A meta-analysis comparing the effect of thiazolidinediones on cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Endogenous gut-derived bacterial endotoxin tonically primes pancreatic secretion of insulin in normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Mechanisms of acute hyperinsulinemia after Kupffer cell phagocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Monocytic expression of CD14 and CD18, circulating adhesion molecules and inflammatory markers in women with diabetes mellitus and impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Toll-like receptors as adjuvant receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Activation of interleukin-6 gene expression through the NF-kappa B transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

An ancient system of host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Toll-like receptor family and signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Interleukin-6 induces cellular insulin resistance in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

In vivo evidences that insulin regulates human polymorphonuclear neutrophil functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Insulin modulates rat intestinal glucose transport: effect of hypoinsulinemia and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00302.2006

10.1152/AJPENDO.00302.2006

21 January 2018

Identifiers

DOI

1 reference

8 November 2017

1 reference